Legal status by country
Is Cartalax legal?
Written by Aaron CuhaReviewed Sep 2026
How Cartalax is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | No FDA evaluation. Retail Cytogen-style capsules are sold as supplements; injectable material is sold as a research chemical. | No MHRA licence. No registered trial anywhere in the world for any compound in this family. | Not on the ARTG. | No Health Canada product licence located under this name. |
US FDA status: Not approved for any indication in the United States and not evaluated by the FDA. Sold as a supplement or a research chemical depending on the vendor.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.